RAS dysregulated cancer cells rely on a high turnover of mitochondria due to their susceptibility to oxidative stress-induced damage; likewise, NF1-deficient tumor cells with RAS dysregulation might also require rapid mitochondrial turnover. This evidence concerns the gene NF1 and cancer.